Paper4713634
Variations in the red cells in paroxysmal nocturnal haemoglobinuria.
Rosse WF. Br J Haematol, 1973. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Variations in the red cells in paroxysmal nocturnal haemoglobinuria. Papers, record 4713634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4713634
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Erythrocytes | Major topic |
| Hemoglobinuria, Paroxysmal | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Complement System Proteins | |
| Erythrocyte Count | |
| Erythrocytes, Abnormal | |
| Erythropoiesis | |
| Female | |
| Hemoglobinometry | |
| Hemolysis | |
| Humans | |
| Male | |
| Middle Aged | |
| Prednisone |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40986193 | Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition. | Drugs | 2025 | https://conductscience.org/library/papers/40986193 | PubMed |
| 32090191 | Paroxysmal Nocturnal Hemoglobinuria: An Underestimated Cause of Pediatric Thromboembolism. | TH Open | 2020 | https://conductscience.org/library/papers/32090191 | PubMed |
| 29982419 | Bone Marrow as a Source of Cells for Paroxysmal Nocturnal Hemoglobinuria Detection. | Am J Clin Pathol | 2018 | https://conductscience.org/library/papers/29982419 | PubMed |
| 27570707 | Pesg PNH diagnosis, follow-up and treatment guidelines. | Am J Blood Res | 2016 | https://conductscience.org/library/papers/27570707 | PubMed |
| 20011245 | The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab. | Ther Clin Risk Manag | 2009 | https://conductscience.org/library/papers/20011245 | PubMed |
| 19171207 | The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. | Semin Hematol | 2009 | https://conductscience.org/library/papers/19171207 | PubMed |
| 12032224 | Paroxysmal nocturnal haemoglobinuria: nature's gene therapy? | Mol Pathol | 2002 | https://conductscience.org/library/papers/12032224 | PubMed |
| 8389477 | Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8389477 | PubMed |
| 6915939 | Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. | J Clin Invest | 1982 | https://conductscience.org/library/papers/6915939 | PubMed |
| 6576376 | Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6576376 | PubMed |
| 6559107 | Characterization of alternative pathway inhibition by a serum derived, low molecular weight complement inhibitor. | Clin Exp Immunol | 1984 | https://conductscience.org/library/papers/6559107 | PubMed |
| 6364432 | The role of complement in immune clearance of blood cells. | Springer Semin Immunopathol | 1983 | https://conductscience.org/library/papers/6364432 | PubMed |
| 6231312 | Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6231312 | PubMed |
| 4855546 | Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4855546 | PubMed |
| 4008653 | Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes. | J Clin Invest | 1985 | https://conductscience.org/library/papers/4008653 | PubMed |
| 3860874 | Enhanced complement-mediated lysis of type III paroxysmal nocturnal hemoglobinuria erythrocytes involves increased C9 binding and polymerization. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3860874 | PubMed |
| 3597779 | Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3597779 | PubMed |
| 3309123 | Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor. | J Exp Med | 1987 | https://conductscience.org/library/papers/3309123 | PubMed |
| 2478585 | Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2478585 | PubMed |
| 2439544 | Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. | J Clin Invest | 1987 | https://conductscience.org/library/papers/2439544 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4713634
GET https://conductscience.org/api/papers/v1/4713634/cited_by?page=2